168 related articles for article (PubMed ID: 21293739)
41. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in rizgary hospital - Erbil.
Al-Naqshbandi AA; Chawsheen MA; Abdulqader HH
J Infect Public Health; 2019; 12(3):330-336. PubMed ID: 30522892
[TBL] [Abstract][Full Text] [Related]
43. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
44. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
Raja NS
J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
[TBL] [Abstract][Full Text] [Related]
45. Antibiotic resistance profile of Gram-negative bacteria isolated from Lafenwa abattoir effluent and its receiving water (Ogun River) in Abeokuta, Ogun state, Nigeria.
Akpan SN; Odeniyi OA; Adebowale OO; Alarape SA; Adeyemo OK
Onderstepoort J Vet Res; 2020 Sep; 87(1):e1-e8. PubMed ID: 33054258
[TBL] [Abstract][Full Text] [Related]
46. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Zhanel GG; DeCorby M; Laing N; Weshnoweski B; Vashisht R; Tailor F; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; McCracken M; Mulvey MR; Johnson J; ; Hoban DJ
Antimicrob Agents Chemother; 2008 Apr; 52(4):1430-7. PubMed ID: 18285482
[TBL] [Abstract][Full Text] [Related]
47. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000.
Mamishi S; Pourakbari B; Ashtiani MH; Hashemi FB
Int J Antimicrob Agents; 2005 Nov; 26(5):373-9. PubMed ID: 16213124
[TBL] [Abstract][Full Text] [Related]
48. Bacteremia and resistant gram-negative pathogens among under-fives in Tanzania.
Christopher A; Mshana SE; Kidenya BR; Hokororo A; Morona D
Ital J Pediatr; 2013 May; 39():27. PubMed ID: 23657136
[TBL] [Abstract][Full Text] [Related]
49. Antimicrobial-resistant enteric bacteria from dairy cattle.
Sawant AA; Hegde NV; Straley BA; Donaldson SC; Love BC; Knabel SJ; Jayarao BM
Appl Environ Microbiol; 2007 Jan; 73(1):156-63. PubMed ID: 17098918
[TBL] [Abstract][Full Text] [Related]
50. Isolates, antimicrobial susceptibility profiles and multidrug resistance of bacteria cultured from samples collected from sheep in New Zealand (2003-2016).
Riley CB; Pfeffer H; MacLachlan C; Wakeford L; Gibson IR; Benschop J; Lawrence KE
N Z Vet J; 2021 Jan; 69(1):20-26. PubMed ID: 32623972
[No Abstract] [Full Text] [Related]
51. Antimicrobial property of a herbal preparation containing Dalbergia sissoo and Datura tramonium with cow urine against pathogenic bacteria.
Yadav H; Yadav M; Jain S; Bhardwaj A; Singh V; Parkash O; Marotta F
Int J Immunopathol Pharmacol; 2008; 21(4):1013-20. PubMed ID: 19144288
[TBL] [Abstract][Full Text] [Related]
52. Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhône-Alpes, France.
Botrel MA; Haenni M; Morignat E; Sulpice P; Madec JY; Calavas D
Foodborne Pathog Dis; 2010 May; 7(5):479-87. PubMed ID: 19919286
[TBL] [Abstract][Full Text] [Related]
53. Antimicrobial activity of imipenem against 1386 clinical isolates.
Belobraydic KA; Qadri SM
Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
[TBL] [Abstract][Full Text] [Related]
54. Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures.
Sharifian M; Karimi A; Tabatabaei SR; Anvaripour N
Jpn J Infect Dis; 2006 Dec; 59(6):380-2. PubMed ID: 17186957
[TBL] [Abstract][Full Text] [Related]
55. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Neu HC; Labthavikul P
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
[TBL] [Abstract][Full Text] [Related]
56. Pattern of Polymicrobial Isolates and Antimicrobial Susceptibility from Blood.
Shabbir S; Jamil S; Hafiz S
J Coll Physicians Surg Pak; 2016 Jul; 26(7):585-8. PubMed ID: 27504550
[TBL] [Abstract][Full Text] [Related]
57. In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patients.
Rolston KV; Alvarez ME; Hoy JF; Alderman HC; Ho DH; Bodey GP
Chemotherapy; 1986; 32(6):506-14. PubMed ID: 3100147
[TBL] [Abstract][Full Text] [Related]
58. Resistant strains isolated from bacteremia patients in northern Norway.
Scheel O; Iversen G
Scand J Infect Dis; 1991; 23(5):599-605. PubMed ID: 1767256
[TBL] [Abstract][Full Text] [Related]
59. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
[TBL] [Abstract][Full Text] [Related]
60. The burden of antimicrobial resistance at tertiary care hospital, southern Ethiopia: a three years' retrospective study.
Alemayehu T; Ali M; Mitiku E; Hailemariam M
BMC Infect Dis; 2019 Jul; 19(1):585. PubMed ID: 31277588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
